NeuroVigil, Inc. is an early stage neuroscience company focused on the analysis of brain signal or EEG data, which currently is used in numerous medical applications but is not automated. NeuroVigil’s patent-pending and proprietary technology provides for extremely rapid, automated, and accurate reading and interpretation of electroencephalogram data, which is a window to the functioning of the brain. The Company’s technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards $250,000 in seed funding to the winner. NeuroVigil Office of the Chairman and Chief Executive Officer is in La Jolla, CA.